Search

Your search keyword '"Borer, Jeffrey S"' showing total 32 results

Search Constraints

Start Over You searched for: Author "Borer, Jeffrey S" Remove constraint Author: "Borer, Jeffrey S" Publisher karger Remove constraint Publisher: karger
32 results on '"Borer, Jeffrey S"'

Search Results

2. Survival after Aortic Valve Replacement for Aortic Regurgitation: Prediction from Preoperative Contractility Measurement.

4. Impact of Beta-Blockade on Cardiac Events in Patients with Chronic Severe Nonischemic Mitral Regurgitation.

5. Efficacy Profile of Ivabradine in Patients with Heart Failure plus Angina Pectoris.

6. Use and Disuse of Observational Research: The Case of Remote Monitoring in Heart Failure.

8. Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population.

9. Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations.

10. Relation of indirect vasodilator use to prognosis in patients with chronic severe mitral regurgitation.

11. Role of oral factor Xa inhibitors after acute coronary syndrome.

12. Nonischemic mitral regurgitation: prognostic value of nonsustained ventricular tachycardia after mitral valve surgery.

13. Off-pump versus on-pump coronary artery bypass grafting in octogenarians: comparison of short-term outcomes and long-term survival.

14. Etiology of valvular heart disease in the 21st century.

16. New oral anticoagulants: great promise for therapeutic advance but great knowledge gaps remain to be filled.

17. Efficacy of I(f) inhibition with ivabradine in different subpopulations with stable angina pectoris.

18. Fibronectin gene expression in aortic regurgitation: relative roles of mitogen-activated protein kinases.

19. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.

21. Similarities and differences in design considerations for cell therapy and pharmacologic cardiovascular clinical trials.

22. Nitric oxide synthase inhibitor (MTR-105) during open-heart surgery. A pilot double-blind placebo-controlled study of hemodynamic effects and safety.

23. Clinical effect of 'pure' heart rate slowing with a prototype If current inhibitor: placebo-controlled experience with ivabradine.

26. Ventricular arrhythmias in mitral regurgitation: frequency, clinical and prognostic importance, management before and after mitral valve surgery.

29. The cellular and molecular basis of heart failure in regurgitant valvular diseases: the myocardial extracellular matrix as a building block for future therapy.

30. The epidemiology of valvular heart disease: an emerging public health problem.

32. Importance of right ventricular performance measurement in selecting asymptomatic patients with mitral regurgitation for valve surgery.

Catalog

Books, media, physical & digital resources